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One-potAbstract Indeno[20,10:5,6]pyrido[2,3-d]pyrimidin-4,6-(5H,11H)dione derivatives were synthesized
regioselectively in high yields by a three-component reaction of 1,3-indanedione, aromatic alde-
hydes and 2,6-diaminopyrimidin-4(3H)-one in the presence of 1,2-dimethyl-N-butanesulfonic acid
imidazolium hydrogen sulfate ([DMBSI]HSO4) ionic liquid as green and reusable catalyst. This pro-
tocol produced the desired products in high yields (87–95%) and short reaction times (3–6 min).
ª 2014 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under the CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Pyridopyrimidines are nitrogen-bearing heterocyclic com-
pounds which have various pharmaceutical applications. In
particular, pyrido[2,3-d]pyrimidine derivatives show variable
biological activities such as anticancer agents inhibiting dihy-
drofolate reductases or tyrosine kinases [1–3], antitumor
[4,5], antiviral [6], antihistaminic [7], anti-inﬂammatory [8],antibacterial [9–12], and also act as cyclin-dependent kinase
4 inhibitors [13]. This structural moiety is present in ramastine
(anti-allergic) [14] and pirenperone (tranquilizer) [15]. As a
result, the compounds of this class have attracted considerable
interests for research. Several MCR methods have been
reported for the synthesis of pyrido[2,3-d]pyrimidines [16–
21]. Although most of these methods offer distinct advantages,
some of them still have their own limitations in terms of yields,
longer reaction times and difﬁcult work-up. In some cases, the
catalysts used are harmful to environment and cannot be
reused. Therefore, an efﬁcient method for the preparation of
pyrido[2,3-d]pyrimidine derivatives is still desirable.
On the other hand, recently, ionic liquids have been
employed as solvent and catalyst for a variety of reactions.
Their use as an environmentally friendly alternative for con-
ventional solvents has gained much attention recently [22–
25]. The use of ionic liquids as reaction medium may offer a
Synthesis of indeno fused pyrido[2,3-d]pyrimidines 571convenient solution to both the solvent emission and catalytic
recycling problem [22,26,27].
We have recently reported efﬁcient and eco-friendly proce-
dures for the preparation of pyrido[2,3-d]pyrimidines [28],
using 1,2-dimethyl-N-butanesulfonic acid imidazolium hydro-
gen sulfate ([DMBSI]HSO4) ionic liquid under solvent-free
conditions. In order to expand the application of
[DMBSI]HSO4 in the synthesis of heterocyclic compounds,
we describe here an efﬁcient and practical method for the prep-
aration of indeno fused pyrido[2,3-d]pyrimidines.2. Experimental
2.1. General
Melting points were recorded on a Bu¨chi B-545 apparatus in
open capillary tubes. IR spectra (KBr) were determined on a
Shimadzo IR-470 spectrometer and FT-IR on a-Bruker.
NMR spectra were recorded on a Bruker DRX (400 MHz)
(1H) and Bruker DRX (100 MHz) (13C) in DMSO-d6 as sol-
vent and TMS as an internal standard; d was quoted in ppm
and J in Hz. Elemental analyses were done on a Carlo–Erba
EA1110CNNO-S analyzer and agreed with the calculated val-
ues. Chemicals were purchased fromMerck and Fluka. All sol-
vents used were dried and distilled according to standard
procedures.
SO3H-functionalized ionic liquid [DMBSI]HSO4 was syn-
thesized according to the literature [26].
2.2. General procedure for preparation of 4a–n
A mixture of equimolar amounts of 1,3-indanedione 1
(1 mmol), arylaldehyde 2 (1 mmol) and 2,6-diamino-4-hydroxy
pyrimidine 3 (1 mmol), in ethylene glycol (5 mL) containing
[DMBSI]HSO4 (0.18 mmol, 0.06 g) was heated under reﬂux
at 120 C. The progress of the reaction was monitored by
TLC (EtOAc/petroleum ether: 1/9). Stirring at 120 C was
continued until disappearance of the starting materials (moni-
tored by TLC). The reaction mixture was cooled and washed
with water to extract the ionic liquid. The solid obtained was
recrystallized from MeOH to furnish the desired pure product
(Table 4).
2.2.1. 2-Amino-5-(4-methoxyphenyl)-3H-
indeno[20,10:5,6]pyrido[2,3-d]pyrimidin-4,6 (5H,11H)-dione
(4a)
Red powder, m.p. 324–326 C, IR (KBr): 3410, 3350, 3080,
2800, 1680, 1590, 1540, 1513, 1480, 1440, 1260, 1240, 1020,
840, 800, 760 cm1. 1H NMR (400 MHz, DMSO-d6): d 3.66
(s, 3H, OCH3), 4.65 (s, 1H, CH), 6.74 (d, J= 8.4 Hz, 1H,
Ar–H), 6.82 (s, br., 2H, NH2), 7.11 (d, J= 8.4 Hz, 1H, Ar–
H), 7.19 (d, J= 10.4 Hz, 1H, Ar–H), 7.29 (t, J= 7.0 Hz,
1H, Ar–H), 7.38 (t, J= 7.0 Hz, 1H, Ar–H), 7.73 (d,
J= 7.2 Hz, 1H, Ar–H), 8.46 (s, br. 1H, NH), 8.97 (s, br.
1H, CO–NH). 13C NMR (100 MHz, DMSO-d6): d 33.3,
55.3, 93.5, 108.7, 113.6, 120.0, 120.4, 128.9, 130.4, 132.0,
134.0, 136.9, 139.2, 154.8, 155.9, 157.8, 191.1. Anal. Cald for
C21H16N4O3 (372.38): C, 67.73; H, 4.33; N, 15.05. Found: C,
67.60; H, 4.21; N, 15.18.2.2.2. 2-Amino-5-(thiophen-2-yl)-3H-
indeno[20,10:5,6]pyrido[2,3-d]pyrimidin-4,6-(5H,11H)dione
(4b)
Red powder, m.p. 327–329 C, IR (KBr): 3449, 3246, 3077,
2926, 1600, 1515, 1450, 1279, 790, 693 cm1. 1H NMR
(400 MHz, DMSO-d6): d 5.03 (s, 1H, CH), 6.81–6.84 (m, 2H,
Ar–H), 7.15 (s, br., 2H, NH2), 7.16 (dd, J= 4.4, 2.0 Hz, 1H,
Ar–H), 7.27 (d, J= 6.8 Hz, 1H, Ar–H), 7.34 (t, J= 7.2 Hz,
1H, Ar–H), 7.39 (t, J= 8.0 Hz, 1H, Ar–H), 7.74 (d,
J= 7.2 Hz, 1H, Ar–H), 10.77 (s, br. 1H, NH), 11.98 (s, br.
1H, CO–NH). 13C NMR (100 MHz, DMSO-d6): d 28.8,
93.6, 107.7, 120.3, 120.8, 123.7, 123.8, 127.1, 130.7, 132.2,
133.9, 136.6, 151.6, 154.8, 155.0, 156.3, 162.9, 190.9. Anal.
Cald for C18H12N4O2S (348.38): C, 62.06; H, 3.47; N, 16.08.
Found: C, 62.20; H, 3.35; N, 15.85.
2.2.3. 2-Amino-5-(4-methylphenyl)-3H-
indeno[20,10:5,6]pyrido[2,3-d]pyrimidin-4,6-(5H,11H)dione
(4c)
Red powder, m.p. 322–323 C, IR (KBr): 3399, 3252, 3070,
2918, 2744, 1667, 1598, 1514, 1449, 1276, 778, 729 cm1. 1H
NMR (400 MHz, DMSO-d6): d 2.19 (s, 3H, CH3), 4.67 (s,
1H, CH), 6.97 (d, J= 8.0 Hz, 1H, Ar–H), 7.08 (s, br., NH2),
7.09 (d, J= 8.0 Hz, 1H, Ar–H), 7.19 (d, J= 6.8, 1H, Ar–
H), 7.29 (t, J= 7.4, 1H, Ar–H), 7.36 (t, J= 7.6, 1H, Ar–H),
7.72 (d, J= 7.2 Hz, 1H, Ar–H), 10.99 (s, br., 2H, NH). 13C
NMR (100 MHz, DMSO-d6): d 21.0, 33.8, 93.6, 108.6, 112.4,
120.0, 120.4, 122.8, 127.9, 128.8, 134.0, 134.2, 135.0, 136.9,
142.3, 144.2, 155.0, 156.2, 191.0. Anal. Cald for C21H16N4O2
(356.38): C, 70.77; H, 4.53; N, 15.72. Found: C, 70.58; H,
4.40; N, 15.65.
2.2.4. 2-Amino-5-(2-chlorophenyl)-3H-
indeno[20,10:5,6]pyrido[2,3-d]pyrimidin-4,6-(5H,11H)dione
(4d)
Red powder, m.p. 327–323 C IR (KBr): 3382, 3195, 3071,
3009, 2886, 1663, 1604, 1535, 1472, 1046, 826, 732 cm1. 1H
NMR (400 MHz, DMSO-d6): d 5.12 (s, 1H, CH), 6.47 (s,
br., 2H, NH2), 7.09 (dt, J= 7.6, 2.0 Hz, 1H, Ar–H), 7.14–
7.18 (m, 2H, Ar–H), 7.24 (d, J= 8.0 Hz, 2H, Ar–H), 7.30 (t,
J= 7.0 Hz, 1H, Ar–H), 7.38 (t, J= 7.2 Hz, 1H, Ar–H), 7.76
(d, J= 7.2 Hz, 1H, Ar–H), 10.54 (s, br., 1H, NH), 10.77 (s,
br. 1H, CO–NH). 13C NMR (100 MHz, DMSO-d6): d 33.0,
93.5, 107.6, 120.2, 120.5, 127.2, 127.7, 129.4, 130.6, 131.6,
132.0, 132.8, 133.9, 136.8, 144.0, 154.8, 155.4, 156.3, 162.0,
190.7. Anal. Cald for C20H13ClN4O2 (376.8): C, 63.75; H,
3.48; N, 14.87. Found: C, 63.60; H, 3.31; N, 14.91 .
2.2.5. 2-Amino-5-(2-chloro-6-ﬂuorophenyl)-3H-
indeno[20,10:5,6]pyrido[2,3-d]pyrimidin-4,6-(5H,11H)dione
(4e)
Red powder, m.p. 317–319 C, IR (KBr): 3390, 3204, 3073,
3009, 2873, 1661, 1605, 1531, 1457, 1275, 1164, 1064, 720,
774 cm1. 1H NMR (400 MHz, DMSO-d6): d 5.38 (s, 1H,
CH), 6.46 (s, br., 2H, NH2), 7.08–7.19 (m, 4H, Ar–H), 7.31
(t, J= 7.2, 1H, Ar–H), 7.39 (t, J= 7.0 Hz, 1H, Ar–H), 7.75
(d, J= 7.2 Hz, 1H, Ar–H), 10.53 (s, br., 1H, NH), 10.80 (s,
br. 1H, CO–NH). 13C NMR (100 MHz, DMSO-d6): d 33.2,
99.0, 116.0, 116.2, 120.2, 120.5, 123.1, 126.6, 128.4, 128.5,
130.7, 132.0, 132.5, 132.6, 134.0, 136.1, 136.6, 154.8, 161.9,
Table 1 Effect of various solvents in the synthesis of 4a, using
[DMBSI]HSO4.
a
Entry Solvent Time (min) Yield (%)b
1 Ethylene glycol 4 95
2 Acetic acid 5 90
3 DMF 6 81
4 EtOH 6 84
5 MeOH 6 82
6 H2O 7 65
7 Acetone 7 60
a Reaction conditions: Catalyst 0.06 g/1 mmol substrate, reaction
temperature 120 C for ethylene glycol and other solvents in reﬂux
conditions.
b Isolated yields.
572 M. Mamaghani et al.190.6. Anal. Cald for C20H12ClFN4O2 (394.8): C, 60.84; H,
3.06; N, 14.19. Found: C, 60.65; H, 3.15; N, 14.10.
2.2.6. 2-amino-5-(naphtalen-1-yl)-3H-
indeno[20,10:5,6]pyrido[2,3-d]pyrimidin-4,6-(5H,11H)dione
(4f)
Red powder, m.p. 325–327 C, IR (KBr): 3424, 3387, 3207,
3050, 2866, 1648, 1602, 1520, 1492, 1450, 1271, 781,
717 cm1. 1H NMR (400 MHz, DMSO-d6): d 5.51 (s, 1H,
CH), 6.45 (s, br., 2H, NH2), 7.10 (d, J= 6.8 Hz, 1H, Ar–H),
7.25–7.29 (m, 2H, Ar–H), 7.34–7.40 (m, 2H, Ar–H), 7.47 (t,
J= 7.0 Hz, 1H, Ar–H), 7.53 (t, J= 7.4 Hz, 1H, Ar–H), 7.67
(d, J= 8.0 Hz, 1H, Ar–H), 7.77 (d, J= 6.8 Hz, 1H, Ar–H),
7.84 (d, J= 8.0 Hz, 1H, Ar–H), 8.61 (s, br., 1H, Ar–H),
10.54 (s, br., 1H, NH), 10.83 (s, br. 1H, CO–NH). 13C NMR
(100 MHz, DMSO-d6): d 33.0, 95.1,109.6, 113.7, 120.1,
120.4, 125.3, 125.6, 125.7, 126.1, 126.2, 126.8, 128.4, 130.4,
131.3, 132.1, 133.5, 133.9, 136.9, 154.6, 155.2, 155.6, 162.2,
191.0. Anal. Cald for C24H16N4O2 (392.41): C, 73.46; H,
4.11; N, 14.28. Found: C, 73.35; H, 4.18; N, 14.20.
2.2.7. 2-Amino-5-(naphtalen-2-yl)-3H-
indeno[20,10:5,6]pyrido[2,3-d]pyrimidin-4,6-(5H,11H)dione
(4g)
Red powder, m.p.: 325–327 C, IR (KBr): 3444, 3249, 3058,
2909, 1637, 1594, 1513, 1448, 1277, 817, 736 cm1. 1H NMR
(400 MHz, DMSO-d6): d 4.88 (s, 1H, CH), 6.58 (s, br., 2H,
NH2), 7.19 (d, J= 7.2 Hz, 1H, Ar–H), 7.31 (t, J= 7.2 Hz,
1H, Ar–H), 7.38–7.44 (m, 4H, Ar–H), 7.66 (s, 1H, Ar–H),
7.73–7.80 (m, 3H, Ar–H), 7.83 (d, J= 7.6 Hz, 1H, Ar–H),
10.77 (s, br. 2H, NH). 13C NMR (100 MHz, DMSO-d6): d
34.7, 93.4, 108.2, 120.2, 120.5, 125.6, 125.8, 126.0, 126.2,
126.2, 127.3, 127.7, 127.8, 128.1, 130.5, 132.2, 133.3, 134.0,
134.9, 136.9, 144.5, 155.7, 163.4, 191.1. Anal. Cald for
C24H16N4O2 (392.41): C, 73.46; H, 4.11; N, 14.28. Found: C,
73.25; H, 4.13; N, 14.12.
2.2.8. 2-Amino-5-(5-methyl-2-thiophen-2-yl)-3H-
indeno[20,10:5,6]pyrido[2,3-d]pyrimidin-4,6-(5H,11H)dione
(4h)
Red powder, m.p. 329–331 C, IR (KBr): 3454, 3246, 2918,
2765, 1667, 1618, 1519, 1450, 1276, 1169, 798, 722 cm1. 1H
NMR (400 MHz, DMSO-d6): d 2.27 (s, 3H, CH3), 4.92 (s,Scheme 1 Synthesis of indenop1H, CH), 6.48–6.49 (m, 3H, NH2 and Ar–H) , 6.58 (d,
J= 3.6, 1H, Ar–H), 7.27 (d, J= 6.8, 1H, Ar–H), 7.34 (t,
J= 7.2, 1H, Ar–H), 7.40 (t, J= 7.2 Hz, 1H, Ar–H), 7.74 (d,
J= 7.2 Hz, 1H, Ar–H), 10.71 (s, br., 1H, NH), d; 10.79 (s,
br., 1H, CO–NH). 13C NMR (100 MHz, DMSO-d6): d 15.4,
28.9, 93.7, 107.7, 120.3, 120.8, 123.5, 125.3, 130.7, 132.2,
133.9, 136.7, 137.0, 149.0, 154.6, 154.7, 156.1, 162.3, 190.9.
Anal. Cald for C19H14N4O2S (362.41): C, 62.97; H, 3.89; N,
15.46. Found: C, 62.85; H, 3.74; N, 15.37.
2.2.9. 5,50-(1,4-Phenylene)bis(2-amino-3H-
indeno[20,10:5,6]pyrido[2,3-d]pyrimidine-4,6-(5H,11H)dione
(4i)
Red powder, m.p. 336–338 C, IR (KBr): 3425, 2926, 1637,
1598, 1515, 1450, 1277, 723 cm1. 1H NMR (400 MHz,
DMSO-d6): d 4.81 (s, 2H, CH), 6.64 (s, br., 4H, NH2), 7.21
(d, J = 6.8 Hz, 2H, Ar–H), 7.32 (t, J = 6.8 Hz, 2H, Ar–H),
7.39 (d, J = 7.6 Hz, 2H, Ar–H), 7.69–7.77 (m, 2H, Ar–H),
7.89 (d, J = 8.0 Hz, 2H, Ar–H), 9.90 (s, br., 2H, NH), 10.08
(s, br., 2H, NH), 10.83 (s, br. 2H, CO–NH). 13C NMR
(100 MHz, DMSO-d6): d 35.8, 99.7, 102.9, 128.7, 128.8,
128.9, 129.8, 130.9, 132.2, 132.4, 132.9, 133.8, 136.4, 136.9,
140.7, 147.9, 159.0, 165.8, 168.5, 200.3, 197.2. Anal. Cald for
C34H22N8O4 (606.59): C, 67.32; H, 3.66; N, 18.47. Found:
67.14; H, 3.49; N, 18.31.yrido[2,3-d]pyrimidines 4a–n.
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As part of our continuing efforts on the development of new
synthetic strategies for the preparation of heterocyclic com-
pounds [28], in this study an efﬁcient protocol was devised
for the preparation of indenopyrido[2,3-d]pyrimidines (4), by
condensation of 1,3-indanedione (1), arylaldehydes (2) and
2,6-diaminopyrimidin-4(3H)-one (3) in the presence of ionic
liquid [DMBSI]HSO4 (Scheme 1).
To optimize the reaction conditions, we screened
different conditions for the synthesis of the desired products.
Therefore, preparation of 2-amino-5-(4-methoxyphenyl)-3Table 2 Effect of various temperatures in the synthesis of 4a
in ethylene glycol using [DMBSI]HSO4.
Entry Temperature (C) Time (min) Yield (%)a
1 80 12 85
2 100 7 89
3 120 4 95
4 130 4 92
a Isolated yields.
Table 3 Effect of various catalysts in the synthesis of 4a in
ethylene glycol at 120 C.
Entry Catalysta Time (min) Yield (%)b
1 – 33 70
2 [DMBSI]HSO4 4 95
3 p-TSA 10 75
4 ZnCl2 13 73
5 L-Proline 16 62
6 DABCO 19 58
7 DBU 21 56
a The amount of catalyst 0.18 mmol/mmol substrate.
b Isolated yields.
Table 4 Synthesis of indeno[20,10:5,6]pyrido[2,3-d]pyrimidin-4,6-(5H
Entry Product Ar Time (m
1 4a 4-MeOC6H4 4
2 4b Thiophen-2-yl 4
3 4c 4-MeC6H4 6
4 4d 2-ClC6H4 5
5 4e 2-Cl-6-FC6H3 5
6 4f Naphtalen-1-yl 4
7 4g Naphthalen-2-yl 6
8 4h 5-Me-thiophen-2-yl 5
9 4i 1,4-Phenylene 6
10 4j C6H5 5
11 4k 4-FC6H4 3
12 4l 4-BrC6H4 4
13 4m 4-ClC6H4 4
14 4n 3-O2NC6H4 5
a Isolated yields.
b Structures of the known products were conﬁrmed by comparison of tH -indeno[20,10:5,6]pyrido[2,3-d]pyrimidin-4,6-(5H,11H)dione
(4a) was selected as model reaction. In initial experiments, dif-
ferent solvents were screened in the presence of ionic liquid
[DMBSI]HSO4 at different temperatures. The results are sum-
marized in Tables 1 and 2. It is evident from the results that
[DMBSI]HSO4/ethylene glycol at 120 C is the most effective
condition producing the product in higher yield (95%) and
lower reaction time (4 min) (Table 1, entry 1). When the reac-
tion was performed on substrates 2a at solvent-free conditions
(120 C), the desired product (4a) was obtained after 6 min in
87% yield.
To compare the efﬁciency of [DMBSI]HSO4 with various
catalysts in ethylene glycol, preparation of 4a was examined
under the optimized conditions using several acidic and basic
catalysts. The result of this study is presented in Table 3, which
clearly conﬁrms the priority of the present catalyst. We also
veriﬁed the amount of catalyst needed for the preparation of
4a. The amount of catalyst plays a crucial role in this reaction.
For example, synthesis of 4a as a model compound, in the
presence of 0.01 g (0.03 mmol) ionic liquid per mmol substrate,
produced 4a in lower yield (75%) in ethylene glycol at 120 C
after 20 min. Increasing the amount of the catalyst to 0.03 g
(0.09 mmol) and 0.06 g (0.18 mmol) resulted in increasing the
yield to 90% and 95% after 6 and 4 min respectively. There-
fore the best result was obtained using 0.06 g (0.18 mmol)
[DMBSI] HSO4/1 mmol substrate.
Using the optimal conditions described in this report,
several derivatives of indenopyridopyrimidines 4a–n were
prepared in high yields (87–95 %) and short reaction times
(3–6 min) (Table 4). No obvious effect of the electronic nature
of substituents in the aromatic aldehydes ring was observed.
Aromatic aldehydes containing electron donating groups (such
as methoxy, methyl group) or electron withdrawing groups
(such as halides, nitro group) were employed and reacted to
give the corresponding products 4a–n in high yield under the
present reaction conditions.
The structures of all the newly synthesized products were
conﬁrmed by spectroscopic (IR, 1H NMR, 13C NMR) and ele-
mental analyses and for the known derivatives, by comparison,11H)dione derivatives 4a–n.
in) Yield (%)a m.p. (C)
Observed Reported [Ref.]b
95 324–326 –
95 327–329 –
87 322–323 –
90 321–323 –
89 317–319 –
96 325–327 –
91 325–327 –
90 329–331 –
90 336–338 –
95 326–328 >300 [21]
93 325–327 >300 [21]
90 327–329 >300 [21]
92 321–323 >300 [21]
93 320–322 >300 [21]
heir spectroscopic data with those of the reported authentic samples.
Figure 1 Bis-indenopyridopyrimidine 4i.
Table 5 Catalyst ([DMBSI]HSO4) recycling in the synthesis
of 4a.
Entry Cycle Time (min) Yield (%)a
1 Fresh 4 95
2 First recycle 4 95
3 Second recycle 4 93
4 Third recycle 4 85
5 Fourth recycle 4 70
a Isolated yields.
574 M. Mamaghani et al.of their spectroscopic data and melting points with those of the
literature reports.
Interestingly these optimal conditions afforded an efﬁcient
protocol for the synthesis of bis-indenopyridopyrimidine 4i
(Fig. 1) in high yield (90%) (entry 9, Table 4).
The catalyst was also recycled and reused in the preparation
of 4a as model compound. After completion of the reaction,Scheme 2 The plausible mechanism of synthesis of indeno[20,10:5
[DMBSI]HSO4.ionic liquid is easily separated from the reaction medium by
washing with water. The washed ionic liquid is distilled under
vacuum to recover the ionic liquid for reuse in subsequent
reactions. The result showed that after three successive runs,
catalytic activity of the catalyst was retained without signiﬁ-
cant loss of activity (Table 5).
The plausible mechanism for the synthesis of 4a–n is out-
lined in Scheme 2.
4. Conclusion
In this report, we have developed a rapid, efﬁcient, and versa-
tile procedure for the synthesis of indeno fused pyrido[2,3-
d]pyrimidine derivatives 4a–n in a regiochemical manner by,6]pyrido[2,3-d]pyrimidin-4,6-(5H,11H)diones in the presence of
Synthesis of indeno fused pyrido[2,3-d]pyrimidines 575the reaction of 1,3-indanedione, 2,6-diaminopyrimidin-4(3H)-
one, and various arylaldehydes in the presence of ionic liquid
[DMBSI]HSO4 in ethylene glycol. High yields, short reaction
times, mild reaction conditions, easy work-up, and cleaner
reaction proﬁles, using a green and recyclable catalyst are
the main advantages of this protocol.Acknowledgment
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